Robert M. Weiss MD, FACS, FAAP

Donald Guthrie Professor of Urology; Director, Pediatric Urology

Departments & Organizations

Yale Medical GroupCancer Center, Yale: Signal TransductionPediatric Urology | Surgery | Urology: General Urology; Pediatric Urology

Research Interests

Smooth muscle pharmacology; Signal transduction; Bladder cancer; Drug delivery more...


  • M.D., SUNY Downstate Medical Center, 1960

Selected Publications

  • Martin DT*, Steinbach J, Liu JC, Shimizu S, Kaimakliotis H, Wheeler MA, Hittelman AB, Saltzman WM, and Weiss RM. Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer. Mol Cancer Ther. 2014 Jan;13(1):71-81.
  • Martin, D.T., Hoimes, C.J., Kaimakliotis, H.Z., Cheng, C.J., Zhang, K., Liu, J., Wheeler, M.A., Kelly, W.K., Tew, G.N., Saltzman, W.M., Weiss, R.M. Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer. Nanomedicine: Nanotechnology, Biology, and Medicine. Nanomedicine. 2013 Nov;9(8):1124-34
  • Weiss, R,M., Guo, S., Shan, A., Shi, H., Rnomano, R-A., Sinha, S., Cantley, L.G., and Guo, J-K.: Brg1 determines urothelial cell fate during ureter development. J. Amer. Soc. Nephrology 24: 618-626, 2013.



Latest News


Edit Profile